Sign in

CIK 0001160308

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841318182
Phone
+51 285113796
Business address
6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
Former names
Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
  1. 4 Open-market buy Director bought 50,000 shares at an average $1.28 ($64,035)
  2. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 4,000 shares at $1.14 ($4,569)
  3. 4 Open-market buy Director bought 40,000 shares at an average $1.11 ($44,485)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 400,000 shares (grant or award)
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 125,000 shares (grant or award)
  10. 4 Exercise or conversion Director acquired 728 shares (option exercise)
  11. 4 Derivatives Options or other derivatives
  12. 4 Grant or award CHIEF MEDICAL OFFICER acquired 125,000 shares (grant or award)
  13. 4 Open-market buy Director bought 35,000 shares at $1.04 ($36,365)
  14. 4 Open-market buy Director bought 25,000 shares at an average $1.05 ($26,214)
  15. 4 Open-market buy CHIEF MEDICAL OFFICER bought 25,000 shares at $1.05 ($26,250)
  16. 4 Exercise or conversion Director acquired 1,172 shares (option exercise)
  17. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 6,500 shares at $1.06 ($6,889)
  18. 4 Open-market buy Director bought 25,000 shares at an average $1.09 ($27,128)
  19. 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 10,000 shares at $1.10 ($10,954)
  20. 4 Open-market buy Director bought 25,000 shares at an average $1.09 ($27,157)

Page 6 of 22 · 436 filings